logo
Select company
Select metric
$ -8.86MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
31
Sector
35
Industry
39
History
38
$ 3.98Close
$ 3.57 - $ 19.8 52-Week Range
Ticker Information

Ticker

CLSD

Company Name

CLEARSIDE BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CLEARSIDE BIOMEDICAL INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLSD - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -8.86M
3/31/2025$ -21.73M
12/31/2024$ -8.9M
9/30/2024$ -14.91M
6/30/2024$ -16.77M
3/31/2024$ -6.06M
12/31/2023$ -19.5M
9/30/2023$ -24.74M
6/30/2023$ 5.81M
3/31/2023$ 6.79M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -7.71M.
  • Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average CF - Chg. Cash has been $ -1.28M.
  • The median CF - Chg. Cash for CLEARSIDE BIOMEDICAL INC during this period was $ -1.39M
  • CLEARSIDE BIOMEDICAL INC reached its highest CF - Chg. Cash over the past 5 years at $ 28.06M.
  • The lowest CF - Chg. Cash recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe $ -24.74M

CLEARSIDE BIOMEDICAL INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
IGC : IGC PHARMA INC $ -1.37MPLUR : PLURI INC $ -475KRANI : RANI THERAPEUTICS HOLDINGS INC $ 5.7MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -3.23MLSTA : LISATA THERAPEUTICS INC $ -11.46MDTIL : PRECISION BIOSCIENCES INC $ -38.77MRLYB : RALLYBIO CORP $ -7.23MICU : SEASTAR MEDICAL HOLDING CORP $ 5.12MONCO : ONCONETIX INC $ -647.03KADVM : ADVERUM BIOTECHNOLOGIES INC $ -84.9M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

CLSD - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -24.74M

Minimum

Sep 30, 2023

$ 28.06M

Maximum

Sep 30, 2022

$ -1.28M

Average

$ -1.39M

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M